Patents by Inventor Nathan Wilde

Nathan Wilde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12024491
    Abstract: The disclosure provides processes for synthesizing compounds for use as CFTR modulators.
    Type: Grant
    Filed: June 20, 2023
    Date of Patent: July 2, 2024
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Berenice Lemercier Lewandowski, Robert Lewis, Adam Looker, Adam Morgan, Stefanie Roeper, Michael Ryan, Juan Gabriel Solsona Rocabert, Nathan Wilde
  • Publication number: 20240166607
    Abstract: The disclosure provides processes for synthesizing compounds for use as CFTR modulators.
    Type: Application
    Filed: June 20, 2023
    Publication date: May 23, 2024
    Inventors: Berenice Lemercier Lewandowski, Robert Lewis, Adam Looker, Adam Morgan, Stefanie Roeper, Michael Ryan, Juan Gabriel Solsona Rocabert, Nathan Wilde
  • Patent number: 11708331
    Abstract: The disclosure provides processes for synthesizing compounds for use as CFTR modulators.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: July 25, 2023
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Berenice Lemercier Lewandowski, Robert Lewis, Adam Looker, Adam Morgan, Stefanie Roeper, Michael Ryan, Juan Gabriel Solsona Rocabert, Nathan Wilde
  • Publication number: 20200290972
    Abstract: The disclosure provides processes for synthesizing compounds for use as CFTR modulators.
    Type: Application
    Filed: November 30, 2018
    Publication date: September 17, 2020
    Inventors: Berenice Lemercier Lewandowski, Robert Lewis, Adam Looker, Adam Morgan, Stefanie Roeper, Michael Ryan, Juan Gabriel Solsona Rocabert, Nathan Wilde